John Cambier

9PUBLICATIONS
69CO-AUTHORS
Tumour immunologyImmunogenetics (incl. genetic immunology)Cellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 14, 2023
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation.

Victor G Lui, Manfred Hoenig, Berenice Cabrera-Martinez

|Jun 30, 2023
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells.

William H Palmer, Laura Ann Leaton, Ana Campos Codo

|Mar 24, 2022
Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model.

Scott M Wemlinger, Chelsea R Parker Harp, Bo Yu

|May 12, 2019
A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.

S Elizabeth Franks, Andrew Getahun, John C Cambier

|Feb 26, 2019
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.

Megan M Tu, Francis Y F Lee, Robert T Jones

|Oct 05, 2018
B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses.

Melissa M Walker, Bergren W Crute, John C Cambier

Pageof 2